The Vitals

FDA Adds Orphan Disease Drugs To Expanded Access Navigator Tool

November 03, 2017
FDA Commissioner Scott Gottlieb announced Thursday (Nov. 2) that FDA is expanding its Expanded Access Navigator, which aims to facilitate pre-approval access to drugs , to include drugs that treat orphan diseases. “Making sure there’s a close relationship with the efforts we take to expand pre-approval access to promising treatments, and the work of our orphan drugs program, is a key step toward maximizing opportunities for patients,” Gottlieb wrote in an FDA Voice blog. The move will help patients gain...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, news from FDA and much more.